Across TCGA pan-cancer cohorts, RBM38-AS1 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of RBM38-AS1’s most consistent transcriptional readouts.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RBM38-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types RBM38-AS1 is over-expressed in tumor, although a few such as BLCA and BRCA show the opposite, repressed pattern.
BLCA, KIRC, and BRCA are the cancer types where RBM38-AS1 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RBM38-AS1 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.